Vnitřní lékařství 1/2020

PŘEHLEDOVÉ ČLÁNKY Sarkopenická obezita – aktuální přehled problematiky | 43  / Vnitř Lék 2020; 66(1): 39–43 /  VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz 10. Tolea MI, Chrisphonte S, Galvin JE. Sarcopenic obesity and cognitive performance. Clin Interv Aging 2018; 13: 1111–1119. 11. De Freitas Junior R, Gonçalves LV, Martins KA et al. arcopenia and obesity sarco‑ penic are associated with recently diagnosed breast cancer? Eur Breast Cancer Conf 2018; 92: S44. 12. Berkel AEM, Klaase JM, de Graaff F et al. Patient’s Skeletal Muscle Radiation Attenuation and Sarcopenic Obesity are Associated with Postoperative Morbidity after Neoadjuvant Chemoradiation and Resection for Rectal Cancer. Dig Surg 2018; 19: 1–8. 13. Zhang WT, Lin J, Chen WS et al. Sarcopenic Obesity Is Associated with Severe Posto‑ perative Complications in Gastric Cancer Patients Undergoing Gastrectomy: a Prospecti‑ ve Study. J Gastrointest Surg Off J Soc Surg Aliment Tract 2018; Available from: http://ez‑ proxy.muni.cz/login?url=https://search.ebscohost.com/login.aspx?direct=true & Auth‑ Type=ip, cookie, uid & db=mdc & AN=29943139 & lang=cs & site=eds‑live & scope=site 14. Bučar PM, Pajek J. Original article: Characterization of deficits across the spectrum of motor abilities in dialysis patients and the impact of sarcopenic overweight and obesi‑ ty. Clin Nutr 2018; 37: 870–877. 15. Gaillard M, Tranchart H, Maitre S et al. Preoperative Detection of Sarcopenic Obesi‑ ty Helps to Predict the Occurrence of Gastric Leak After Sleeve Gastrectomy. Obes Surg 2018; 28: 2379–2385. 16. Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: A cross talk between age‑associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 2017; 35: 200–221. 17. Steffl M, Chrudimsky J, Tufano JJ. Using relative handgrip strength to identify children at risk of sarcopenic obesity. Plos One 2017; 12: e0177006–e0177006. 18. Kyoung MK. Uncertainty and Diversity in the Methods Defining Sarcopenia and Sar‑ copenic Obesity. J Obes Metab Syndr 2017; 26: 235–236. 19. Yang YX, ChongMS, LimWS et al. Validity of estimatingmuscle and fat volume from a sin‑ gleMRIsection inolderadultswithsarcopeniaandsarcopenicobesity.ClinRadiol2017;72:427. 20. Bano G, Trevisan C, Carraro S et al. Review article: Inflammation and sarcopenia: A sys‑ tematic review and meta‑analysis. Maturitas 2017; 96: 10–15. 21. Kim TN, Park MS, Lee EJ et al. The association of low muscle mass with soluble re‑ ceptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS). Diabetes Metab Res Rev 2018; Available from: http://ezproxy.muni.cz/lo‑ gin?url=https://search.ebscohost.com/login.aspx?direct=true & AuthType=ip, cookie, uid & db=mdc & AN=29271076 & lang=cs & site=eds‑live & scope=site 22. Dieli‑Conwright CM, Courneya KS, Demark‑Wahnefried W et al. Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomar‑ kers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. J Clin Oncol 2018; 36: 875. 23. Park J, Kwon Y, Park H. Effects of 24-Week Aerobic and Resistance Training on Carotid Artery Intima‑Media Thickness and Flow Velocity in Elderly Women with Sarcopenic Obe‑ sity. J Atheroscler Thromb 2017; 24: 1117–1124. 24. Gando Y. Carotid Artery Parameters After Combined Exercise Training in Women with Sarcopenic Obesity. J Atheroscler Thromb 2017; 24: 1090–1091. 25. Carpentier AC, Blondin DP, Virtanen KA et al. Brown Adipose Tissue Energy Metabolism in Humans. Front Endocrinol 2018; Available from: http://ezproxy.muni.cz/login?url=https://se‑ arch.ebscohost.com/login.aspx?direct=true&AuthType=ip,cookie,uid&db=edsdoj&AN=ed‑ sdoj.839501393fad4c8fbd5dedfb9d0b84f5& lang=cs&site=eds‑live&scope=site 26. Giralt M, Villarroya F White, Brown Z. Beige/Brite: Different Adipose Cells for Different Functions? Endocrinology 2013; 154: 2992–3000. 27. Villarroya J, Cereijo R, Villarroya F. An endocrine role for brown adipose tissue? Am J Physiol Endocrinol Metab 2013; 305: E567–E572. 28. Cereijo R, Villarroya J, Villarroya F. Non‑sympathetic control of brown adipose tissue. Int J Obes Suppl 2015; 5: S40–S44. 29. Boengler K, Kosiol M, Mayr M et al. Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue. J Cachexia Sarcopenia Muscle 2017; 8: 349–369. 30. Barazzoni R, Bischoff S, Boirie Y et al. Sarcopenic Obesity: Time to Meet the Challenge. Obes Facts 2018; 11: 294–305. 31. Drey M, Berr CM, Reincke M et al. Cushing’s syndrome: a model for sarcopenic obesi‑ ty. Endocrine 2017; 57: 481-485. Víte, že listovačky časopisu Klinická farmakologie a farmacie jsou volně dostupné on-line? Mohou být přínosné i pro vás… V posledních číslech najdete tato hlavní témata: Farmakoterapie v těhotenství a při kojení (4/2019) Nežádoucí účinky léčiv (3/2019) Farmakoterapie v anesteziologii (2/2019) Oftalmologie (1/2019) ... a mnoho článků z jiných oblastí medicíny a farmacie www. klinickafarmakologie.cz